Smart multifunctional GLA-nanoformulation for Fabry disease

Projektinformationen

Smart-4-Fabry

ID Finanzhilfevereinbarung: 720942

DOI 10.3030/720942

Projekt abgeschlossen

EK-Unterschriftsdatum 22 November 2016

Startdatum 1 Januar 2017

Enddatum 31 Dezember 2020

Finanziert unter

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies

Gesamtkosten € 5 844 508,63

EU-Beitrag € 5 844 508,63

Koordiniert durch

CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.
Spain

Leistungen

Documents, reports (4)

Linkedin, Youtube, Twitter

Feeding and reporting activities of the social communities

Press and social media repercussion

Report on press appearances and social media repercussion

Use and dissemination Plan

Report defining the activities related to the use and dissemination of the project's results

Compilation of scientific papers published

Report with a Compilation of the scientific papers published during the project

Other (2)

Smart-4-Fabry Final Expo
Project/group presentations

Group presentation/special seminar at appropriate pharmaceutical conference

Websites, patent fillings, videos etc. (1)

Smart-4-Fabry public website

Development and follow-up of a website with the information/activities of the project

Veröffentlichungen

Peer reviewed articles (2)

Synthesis of Stable Cholesteryl–Polyethylene Glycol–Peptide Conjugates with Non-Disperse Polyethylene Glycol Lengths

Autoren: Edgar Cristóbal-Lecina, Daniel Pulido, Pau Martin-Malpartida, Maria J. Macias, Fernando Albericio, Miriam Royo
Veröffentlicht in: ACS Omega, Ausgabe 5/10, 2020, Seite(n) 5508-5519, ISSN 2470-1343
Herausgeber: ACS Publications
DOI: 10.1021/acsomega.0c00130

Impact of Chemical Composition on the Nanostructure and Biological Activity of α-Galactosidase-Loaded Nanovesicles for Fabry Disease Treatment

Autoren: Judit Tomsen-Melero, Solène Passemard, Natalia García-Aranda, Zamira Vanessa Díaz-Riascos, Ramon González-Rioja, Jannik Nedergaard Pedersen, Jeppe Lyngsø, Josep Merlo-Mas, Edgar Cristóbal-Lecina, José Luis Corchero, Daniel Pulido, Patricia Cámara-Sánchez, Irina Portnaya, Inbal Ionita, Simó Schwartz, Jaume Veciana, Santi Sala, Miriam Royo, Alba Córdoba, Dganit Danino, Jan Skov Pedersen,
Veröffentlicht in: ACS Applied Materials & Interfaces, 2021, ISSN 1944-8244
Herausgeber: American Chemical Society
DOI: 10.1021/acsami.0c16871

Rechte des geistigen Eigentums

Patent (3)

ES: “LIPOSOMAS FUNCIONALIZADOS ÚTILES PARA LA LIBERACIÓN DE COMPUESTOS BIOACTIVOS”.INT: “FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS”

Antrags-/Publikationsnummer: ES P201231020
Datum: 2012-06-29

ES: “LIPOSOMAS FUNCIONALIZADOS ÚTILES PARA LA LIBERACIÓN DE COMPUESTOS BIOACTIVOS”.INT: “FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS”

Antrags-/Publikationsnummer: ES P201231020
Datum: 2012-06-29

ES: “LIPOSOMAS FUNCIONALIZADOS ÚTILES PARA LA LIBERACIÓN DE COMPUESTOS BIOACTIVOS”.INT: “FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS”

Antrags-/Publikationsnummer: ES P201231020
Datum: 2012-06-29
Antragsteller: FUNDACIO PARC CIENTIFIC DE BARCELONA